82Y.F ORTOMA AB B
- Market cap
- EUR 28.4M
- P/E
- -
- P/B
- 1.79x
- ROE
- -33.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 82Y.F undervalued?
Graham numberThe Graham number of ORTOMA AB B cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ORTOMA AB B fundamental analysis
No fundamental analysis for ORTOMA AB B yet.
ORTOMA AB B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ORTOMA AB B
Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and O…
Full company profileORTOMA AB B financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ORTOMA AB B annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 38.1M | 49.1M | 64.6M | 52.4M |
| Gross Profit | 20.0M | 23.4M | 56.0M | 48.9M | 53.7M | 23.9M |
| Operating Income | -13.3M | -15.0M | 2.11M | -14.6M | -19.5M | -58.6M |
| EBITDA | - | -14.9M | -15.2M | 588K | -4.35M | -45.2M |
| Net Income | -10.8M | -15.8M | -21.9M | -11.6M | -19.2M | -58.4M |
| EPS | -0.46 | -0.66 | -0.59 | -0.31 | -0.52 | -1.25 |
| Balance Sheet | ||||||
| Total Assets | 134M | 151M | 192M | 181M | 161M | 196M |
| Total Liabilities | 3.95M | 37.0M | 18.8M | 19.1M | 18.6M | 22.1M |
| Shareholders' Equity | 130M | 114M | 174M | 162M | 143M | 174M |
| Cash & Short-term Investments | 12.6M | 8.11M | 51.4M | 17.8M | 20.8M | 62.7M |
| Cash Flow | ||||||
| Operating Cash Flow | -15.2M | -8.29M | 13.4M | -22.0M | 6.04M | -37.3M |
| Capital Expenditure | 20.2M | 23.4M | 23.9M | 11.6M | 3.09M | 0.00 |
| Free Cash Flow | -35.4M | -31.7M | -10.6M | -33.6M | 2.95M | -37.3M |
| Ratios | ||||||
| ROE | -8.3% | -13.8% | -12.6% | -7.2% | -13.4% | -33.5% |
| ROA | -8.1% | -10.4% | -11.4% | -6.4% | -11.9% | -29.7% |
| Net Profit Margin | - | - | -57.3% | -23.7% | -29.7% | -111.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ORTOMA AB B dividends
ORTOMA AB B has not paid dividends in the last 5 fiscal years.
Who owns ORTOMA AB B
- Insiders 0.00%
- Institutions 0.01%
- Public & others 99.99%
- Shares outstanding 45.1M
- Free float 33.9M
ORTOMA AB B company profile
- Company name
- ORTOMA AB B
- Ticker
- 82Y.F
- ISIN
- SE0005676103
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 14
- Fiscal year end
- December
- Address
- Falkenbergsgatan 3, Gothenburg, Sweden, 412 85
- Phone
- 46 0 31 44 17 16
- Website
- ortoma.com
About ORTOMA AB B
Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position. The company was founded in 2001 and is based in Gothenburg, Sweden.
ORTOMA AB B management
6- Fredrik StrombergChief Executive Officer · born 1973
- Anna ZylaHead of Operations
- Carianne NilssonHead of Sales & Marketing
- Dr. Andreas Pettersson Ph.D.Head of Clinical Operations
- Hassan NematiHead of Technical Research
- Fredrik HedbergHead of QA/RA